142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

311450
State Laws on Prescription Drug Misuse, Abuse, and Overdose

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Wednesday, November 19, 2014 : 11:10 AM - 11:30 AM

Akshara Menon, JD, MPH , Public Health Law Program, Office for State, Tribal, Local and Territorial Support, Centers for Disease Control and Prevention, Atlanta, GA
In the past decade, prescription drug abuse, misuse, and diversion have led to an epidemic of overdose-related deaths across the United States. We have embarked on a joint effort in conjunction with another program to catalogue and analyze common legal strategies related to the prevention of deaths from prescription drug overdose. The laws include both statutes and regulations across all 50 states and the District of Columbia relating to:

•             Doctor shopping

•             Pain management clinics

•             Tamper-resistant prescription forms

•             Prescription limits

•             Proof of identification

•             Physical examinations

•             Prescription drug overdose emergencies

This session will describe our assessment of all seven types of legal strategies that relate to prescription drug misuse, abuse, and overdose. Specific examples of states’ current laws will also be provided. Additionally, this session will include a brief summary of the evidence of harm and effectiveness related to each law type, while pointing out gaps in current evaluation of the laws. 

 

Learning Areas:

Public health or related laws, regulations, standards, or guidelines

Learning Objectives:
Identify seven types of laws relevant to preventing prescription drug abuse, misuse, and diversion Describe the specific language used in state prescription drug laws Discuss research and evaluation gaps that currently exist for laws aimed at preventing prescription drug overdose

Keyword(s): Law, Prescription Drug Abuse and Misuse

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am Lead of the team engaged in legal assessment work of state laws on prescription drug misuse, abuse, and overdose at the CDC's Public Health Law Program.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.